George Bautovich is an academic consultant Nuclear Medicine physician presently in the Department of Nuclear Medicine at Royal North Shore Hospital at St Leonards in Sydney, and previously at Royal Prince Alfred Hospital in Camperdown in Sydney.

He has retired from clinical Nuclear Medicine. He has throughout had a strong devoted research interest. He was the first to measure the beta-lipoprotein-protein in humans, developing a radioimmunoassay ab initio. He made contributions in aerosol delivery to specific sites in the respiratory tree, mucociliary clearance measurement, and the use of aerosols to treat patients with cystic fibrosis.  He contributed significant advances to labelling red blood cells with Technetium-99m in-vivo, in-vivtro and in vitro, developing gated heart blood pool scanning from scratch, and contributed to the introduction and advancement of myocardial perfusion imaging with Thallium-201 and subsequently Technetium-99m MIBI. He successfully imaged Deep Venous Thrombosis and Pulmonary Embolus with a Technetium-99m monoclonal antibody (3B6). His present interest is a collaborative project developing aptamers that specifically target insoluble cross-linked fibrin in thrombus without any targeting of fibrinogen, fibrin degradation products, D-dimer, or any other constituent in the blood of patients who have abnormal clot in their circulation.

George is married with six children. He has a farm near Goulburn in New South Wales growing olive trees to produce extra virgin olive oil.